Re-emergence of striatal cholinergic interneurons in movement disorders.
about
Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsDopamine release in the basal gangliaSubtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disordersCentrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in ratsDiagnosis and treatment of dystoniaAging, motor skill, and the energy cost of walking: implications for the prevention and treatment of mobility decline in older personsDopaminergic modulation of striatal neurons, circuits, and assembliesFunctional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's DiseaseDevelopmental profile of the aberrant dopamine D2 receptor response in striatal cholinergic interneurons in DYT1 dystoniaC. elegans dopaminergic D2-like receptors delimit recurrent cholinergic-mediated motor programs during a goal-oriented behaviorNeuronal circuits and physiological roles of the basal ganglia in terms of transmitters, receptors and related disordersImpaired novelty acquisition and synaptic plasticity in congenital hyperammonemia caused by hepatic glutamine synthetase deficiencyThe mouse homeobox gene Gbx2 is required for the development of cholinergic interneurons in the striatumStriatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystoniaTargeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission.A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learningEnhanced sensitivity to group II mGlu receptor activation at corticostriatal synapses in mice lacking the familial parkinsonism-linked genes PINK1 or Parkin.Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease.Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia.Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.GRK3 suppresses L-DOPA-induced dyskinesia in the rat model of Parkinson's disease via its RGS homology domainREST and CoREST modulate neuronal subtype specification, maturation and maintenance.Dopamine D2-receptor activation elicits akinesia, rigidity, catalepsy, and tremor in mice expressing hypersensitive {alpha}4 nicotinic receptors via a cholinergic-dependent mechanism.Circuits Regulating Pleasure and Happiness in Bipolar Disorder.Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice.Convergent evidence for abnormal striatal synaptic plasticity in dystonia.Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents.Differential Alteration in Expression of Striatal GABAAR Subunits in Mouse Models of Huntington's DiseaseDifferential processing of thalamic information via distinct striatal interneuron circuits.Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneuronsDeficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.Mice with selective elimination of striatal acetylcholine release are lean, show altered energy homeostasis and changed sleep/wake cycle.Development of allosteric modulators of GPCRs for treatment of CNS disordersEnhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian miceCholinergic interneurons mediate fast VGluT3-dependent glutamatergic transmission in the striatum.Developmentally regulated and evolutionarily conserved expression of SLITRK1 in brain circuits implicated in Tourette syndrome.
P2860
Q22251215-ED2F6F9A-C89F-4621-B6EC-F18428F2E4FCQ22251247-050E8100-F905-4C67-8241-94278C845950Q24605472-F50C19C9-E1F7-403C-8CFF-CFBA2902F39FQ24652668-D5EE54F1-EB6D-46E5-BB0B-FB02934E96B5Q26830473-88ED8A0C-8EE0-4456-8AC8-8A2D02605C0FQ26859174-7C54A9D6-3B38-482B-8323-F126C09FF37BQ26862387-039EE9EC-E2AE-4D70-AE0C-5A61D7D3FE8AQ27015687-E6723B8B-B868-4DC1-994B-7D26876BC598Q27321884-96E786B9-6493-42D7-997C-C6F2E4669A7DQ27330422-2F6C78FD-BE63-4F9F-890A-9BBA11490CB1Q28069529-DA957985-93AF-496C-A11C-E01BBF1CCE41Q28397860-669D6E95-9ADA-45C8-B1EE-1384D3F29861Q28585998-DF0ACA89-1B14-4519-ADD7-73E7A959CFE0Q28648007-CA3571C0-749E-4045-8DF4-E2D2A5AD1996Q30446914-8A188835-F2FD-4996-A362-F0F6C11C1C71Q30472919-E97F21CA-837B-435F-960C-D42B8C090EF4Q30488913-A53C1421-08F5-4B0B-8180-017100BCBDD8Q30492449-6A51A493-8D10-4E8C-9749-4914D046BD40Q30539113-B3303888-71F6-4638-8717-E193DC6449E0Q30547556-BB008B02-2C59-4556-BD6B-84E8F16C1109Q30630420-A6FAC049-3A30-4FAE-8395-F73FD20A76E6Q30653115-2FD9E40E-0163-4D01-AAAC-325BDEC9AA9FQ30974357-67FB8E5F-9F01-46EC-B618-2A6EC728E908Q33552861-E3919859-18E8-4382-8514-B08B223B99B4Q33710918-7F4EF027-05AE-4EB1-ABBD-CBBB83477F76Q33723034-19657090-5BAA-4A0A-92FD-44055D744DC1Q33756951-FD6AF56A-7974-4A8F-BED2-6843045BA7B8Q33770416-14F61624-D2E7-4D92-8225-C242BAF688C4Q33813021-58FFC0D3-BC50-4D62-95CE-5C67E8291924Q33815670-AE922E34-878C-464E-99E7-B32DB2769516Q33819387-3C96F363-FBDB-4ACB-BD49-865A40D61DEAQ33835219-854600E7-CF69-44C1-9973-A018B90D6E78Q33856698-6932ADE1-8994-413E-AE7B-CF9C2AA7CF6DQ33917311-907A0DA3-E639-4C2A-9CE8-0CB994D0F550Q34076241-6DC7C876-5A19-4D1E-B158-1D5C35BDD70BQ34317631-DDAD1D1F-EFFA-4C2F-980F-E2629457BA5AQ34373958-8C9D5E87-4E29-4257-83BE-8B58CAD27425Q34490801-D243E35A-EE68-4D30-BC51-5B60003ED6A4Q34841740-FBEA8EEE-0200-4C6A-AAFA-894D8FBB0750Q34910081-4C7FBC5C-1CFC-41E2-81A4-FCF263343D2D
P2860
Re-emergence of striatal cholinergic interneurons in movement disorders.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Re-emergence of striatal cholinergic interneurons in movement disorders.
@en
type
label
Re-emergence of striatal cholinergic interneurons in movement disorders.
@en
prefLabel
Re-emergence of striatal cholinergic interneurons in movement disorders.
@en
P2093
P1476
Re-emergence of striatal cholinergic interneurons in movement disorders.
@en
P2093
Antonio Pisani
D James Surmeier
Giorgio Bernardi
P304
P356
10.1016/J.TINS.2007.07.008
P577
2007-09-29T00:00:00Z